On Aug. 27, 2020, the U.S. Departments of Health and Human Services and the Department of and Defense awarded a contract for $760 million to Abbott for delivery of 150 million rapid, Abbott BinaxNOW COVID-19 Ag Card Point of Care (POC) SARS-CoV-2 diagnostic tests to expand strategic, evidence-based testing in the U.S.